Hikma Pharmaceuticals MENA News and Activities

Hikma Pharmaceuticals MENA is owned by Hikma Pharmaceuticals.

Hikma Pharmaceuticals is one of the...

• FTSE 350;
• Stoxx 600;
• TOB Iconic 10,000.

Hikma Pharmaceuticals is a company listed under the stock ticker HIK (GB).

Hikma Pharmaceuticals has a direct presence in 3 countries.

Hikma Pharmaceuticals has 3 subsidiaries including Hikma Generics, Hikma Pharmaceuticals MENA and Hikma Ventures.

They are in:

• Pharmaceuticals50%
• Biotechnology25%
• Other25%

View the org chart displaying its 3 main executives

Most searched biographies at Hikma Pharmaceuticals MENA

• Asma Al Anani, Vice President, Marketing
• Mohamed Abu Hamdah, Marketing Director
• Mazen Darwazah, President

Popular executive movements at Hikma Pharmaceuticals MENA

• Mohamed Abu Hamdah, who was Associate Director, Marketing, is promoted to Marketing Director  (posted on July 6 2026).

Popular executive movements at Hikma Pharmaceuticals

• Khalid Nabilsi, who was Chief Financial Officer and Director, is promoted to Deputy Chief Executive Officer, North America and Europe  (posted on February 26 2026).
• Areb Kurdi who was Vice President of Finance and Accounting, becomes Acting Chief Financial Officer  (posted on February 26 2026).
• Victoria Hull, who was Director, is promoted to Chairman of the Board  (posted on February 26 2026).

Click here to view some more movements at Hikma Pharmaceuticals

Create your alert
to follow the executive moves at Hikma Pharmaceuticals MENA.

Hikma Pharmaceuticals has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Hikma Pharmaceuticals MENA

Social media about Hikma Pharmaceuticals MENA

• Hikma Pharmaceuticals MENA on Wikipedia, Google News & Yahoo Finance
• Hikma Pharmaceuticals MENA on LinkedIn, X (Twitter) & YouTube